Assay ID | Title | Year | Journal | Article |
AID745401 | Antibacterial activity against Streptococcus pneumoniae SR26207 clinical isolate assessed as growth inhibition by CLSI broth microdilution method | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID209934 | Inhibitory activity against Streptococcus pyogenes | 1996 | Journal of medicinal chemistry, Sep-27, Volume: 39, Issue:20
| New directions in antibacterial research. |
AID208011 | The compound was evaluated for its anti-bacterial activity against Streptococcus pneumoniae UC 9912 | 1998 | Journal of medicinal chemistry, Dec-17, Volume: 41, Issue:26
| Nitrogen-carbon-linked (azolylphenyl)oxazolidinones with potent antibacterial activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID206787 | Inhibitory activity against MSSA | 1996 | Journal of medicinal chemistry, Sep-27, Volume: 39, Issue:20
| New directions in antibacterial research. |
AID383564 | Antibacterial activity against Staphylococcus aureus ATCC 29213 by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID206088 | In vitro anti-streptococcal activity against Streptococci species (viridans) [25]* expressed as geometric mean | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID125242 | The compound was evaluated for its anti-bacterial activity against Moraxella catarrhalis UC 30610 | 1998 | Journal of medicinal chemistry, Dec-17, Volume: 41, Issue:26
| Nitrogen-carbon-linked (azolylphenyl)oxazolidinones with potent antibacterial activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID65385 | Inhibitory activity against Enterococcus faecalis UC9217 | 2000 | Journal of medicinal chemistry, Mar-09, Volume: 43, Issue:5
| Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID383565 | Antibacterial activity against Staphylococcus aureus ATCC 9144 by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID125104 | Inhibitory activity against Moraxella catarrhalis | 1996 | Journal of medicinal chemistry, Sep-27, Volume: 39, Issue:20
| New directions in antibacterial research. |
AID1369124 | Antibacterial activity against Acinetobacter baumannii ATCC 17978 after 18 hrs by broth microdilution method | 2018 | Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
| A Synthetic Dual Drug Sideromycin Induces Gram-Negative Bacteria To Commit Suicide with a Gram-Positive Antibiotic. |
AID745400 | Antibacterial activity against Haemophilus influenzae SR27914 clinical isolate assessed as growth inhibition by CLSI broth microdilution method | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID319146 | Solubility in phosphate buffer at pH 7 | 2008 | Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
| Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections. |
AID67579 | Minimum inhibitory concentration against Enterococcus faecalis UC9217 | 1998 | Journal of medicinal chemistry, Sep-10, Volume: 41, Issue:19
| Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring. |
AID244815 | Minimum inhibitory concentration against Staphylococcus aureus A15090 | 2005 | Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
| Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid. |
AID50998 | In vitro antibacterial activity against Clostridium perfringens strain ATCC 13124 | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID134123 | Protective dose of subcutaneously administered compound against intraperitoneally-induced septicaemia model (Staphylococcus aureus HT18) in murine | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID133300 | Minimum inhibitory concentration of the subcutaneously administered compound evaluated against Staphylococcus aureus HT-18 strain in mice | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID201444 | Inhibitory activity against Methicillin-resistant Staphylococcus epidermidis UC12084 | 2000 | Journal of medicinal chemistry, Mar-09, Volume: 43, Issue:5
| Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID207511 | Minimum inhibitory concentration against Staphylococcus aureus UC9213 | 1998 | Journal of medicinal chemistry, Sep-10, Volume: 41, Issue:19
| Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring. |
AID262232 | Antibacterial activity against Staphylococcus aureus ATCC 29213 | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials. |
AID383556 | Antibacterial activity against Bacillus cereus ATCC 11778 by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID745402 | Antibacterial activity against Moraxella catarrhalis SR26840 clinical isolate assessed as growth inhibition by CLSI broth microdilution method | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID197767 | Compound was evaluated for metabolic stability via In vitro Rat 5E6 cell at 50 uM concentration | 2003 | Journal of medicinal chemistry, Jan-16, Volume: 46, Issue:2
| Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens. |
AID205680 | Minimum inhibitory concentration against Staphylococcus aureus MTCC 96; Not determined | 2004 | Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
| Oxazolidinone: search for highly potent antibacterial. |
AID1553369 | Inhibition of protein synthesis in mitochondria (unknown origin) assessed as [35S]methionine incorporation incubated for 15 to 120 mins by paper disk assay | 2019 | Bioorganic & medicinal chemistry letters, 09-15, Volume: 29, Issue:18
| Incorporation of a chiral gem-disubstituted nitrogen heterocycle yields an oxazolidinone antibiotic with reduced mitochondrial toxicity. |
AID308916 | Antibacterial activity against Staphylococcus aureus ATCC 33591 by broth microdilution method | 2007 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
| Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. |
AID134119 | Protective dose of subcutaneously administered compound against intraperitoneally-induced septicaemia model (Staphylococcus agalactiae B1HT3 strain) in murine | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID745382 | Antibacterial activity against methicillin-resistant Staphylococcus aureus SR3637 infected in JCL/ICR mouse systemic infection model assessed as mortality administered as iv measured over 7 days | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID201408 | Inhibitory activity against Methicillin-resistant Staphylococcus aureus UC6685 | 2000 | Journal of medicinal chemistry, Mar-09, Volume: 43, Issue:5
| Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID383566 | Antibacterial activity against Staphylococcus aureus ATCC 14154 by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID206127 | In vitro antibacterial activity against ciprofloxacin-resistant Staphylococcus aureus (CRSA) C6043. | 1999 | Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
| Synthesis and in vitro activity of new oxazolidinone antibacterial agents having substituted isoxazoles. |
AID226024 | Protective dose of subcutaneously administered compound against intraperitoneally-induced septicaemia model (vancomycin resistant Enterococci faecium D3AP9 strain ) in murine | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID112683 | In vivo antibacterial activity against Enterococcus faecium strain UC 15090 administered perorally in mice | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID206090 | Minimum inhibitory concentration evaluated against Streptococci species (viridans) [25]* | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID223270 | Dose required to cure 50% of Staphylococcus aureus infected mice in the presence of vancomycin when administered orally; value ranges from 2.5-6.4 | 2000 | Journal of medicinal chemistry, Mar-09, Volume: 43, Issue:5
| Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID745383 | Antibacterial activity against methicillin-resistant Staphylococcus aureus SR3637 assessed as growth inhibition by CLSI broth microdilution method | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID128015 | Compound was tested against Staphylococcus aureus UC9213 after po administration in mouse | 1998 | Journal of medicinal chemistry, Sep-10, Volume: 41, Issue:19
| Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring. |
AID262231 | Antibacterial activity against Staphylococcus aureus ATCC 14154 | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials. |
AID27799 | Volume distribution in Male Sprague-Dawley Rat (25 mg/kg po); NC denotes not calculated | 2003 | Journal of medicinal chemistry, Jan-16, Volume: 46, Issue:2
| Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens. |
AID266689 | Antibacterial activity against Staphylococcus aureus ATCC 25923 | 2006 | Bioorganic & medicinal chemistry letters, Jul-15, Volume: 16, Issue:14
| 3D QSAR studies of N-4-arylacryloylpiperazin-1-yl-phenyl-oxazolidinones: a novel class of antibacterial agents. |
AID383569 | Antibacterial activity against linezolid-resistant Staphylococcus aureus NRS 120 with G 2576T mutation by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID206841 | Minimum inhibitory concentration evaluated against Staphylococcus species resistant to oxacillin and ofloxacin [47]* | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID94375 | In vitro antibacterial activity against Klebsiella pneumoniae strain UC 12081 | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID29427 | Oral bioavailability in rat (Sprague-Dawley) (male) (dose 10 mg/kg i.v.) | 2003 | Journal of medicinal chemistry, Jan-16, Volume: 46, Issue:2
| Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens. |
AID308921 | Antibacterial activity against Staphylococcus aureus ATCC 25923 by broth microdilution method | 2007 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
| Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. |
AID206786 | Inhibitory activity against MRSA | 1996 | Journal of medicinal chemistry, Sep-27, Volume: 39, Issue:20
| New directions in antibacterial research. |
AID223279 | Dose required to cure 50% of Staphylococcus aureus infected mice when administered orally; value ranges from 1.4-3.8 | 2000 | Journal of medicinal chemistry, Mar-09, Volume: 43, Issue:5
| Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID66098 | Inhibitory activity against Enterococcus faecium | 1996 | Journal of medicinal chemistry, Sep-27, Volume: 39, Issue:20
| New directions in antibacterial research. |
AID67894 | The compound was evaluated for its anti-bacterial activity against Enterococcus faecalis UC 9217 | 1998 | Journal of medicinal chemistry, Dec-17, Volume: 41, Issue:26
| Nitrogen-carbon-linked (azolylphenyl)oxazolidinones with potent antibacterial activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID133297 | Minimum inhibitory concentration of the subcutaneously administered compound evaluated against Staphylococcus aureus GR56 strain resistant to oxacillin in mice | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID79584 | Inhibitory activity against Haemophilus influenzae UC30063 | 2000 | Journal of medicinal chemistry, Mar-09, Volume: 43, Issue:5
| Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID245167 | Minimum inhibitory concentration against homogeneously methicillin-resistant Staphylococcus aureus A27223 | 2005 | Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
| Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid. |
AID40483 | Minimum inhibitory concentration against Bacillus pumilus MTCC 1607 | 2004 | Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
| Oxazolidinone: search for highly potent antibacterial. |
AID206281 | In vitro antibacterial activity against Staphylococcus aureus (S. a.) ATCC 29213. | 1999 | Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
| Synthesis and in vitro activity of new oxazolidinone antibacterial agents having substituted isoxazoles. |
AID66561 | Minimum inhibitory concentration evaluated against enterococci species susceptible to vancomycin [26]* | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID226027 | Protective dose of subcutaneously administered compound against intraperitoneally-induced septicaemia model (vancomycin resistant Enterococci faecium D3HT12 strain ) in murine | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID245196 | Minimum inhibitory concentration against heterogeneously methicillin-resistant Staphylococcus aureus A27218 | 2005 | Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
| Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid. |
AID91253 | Compound was evaluated for metabolic stability via In vitro Human 5E6 cell at 25 uM concentration; ND denotes not determined | 2003 | Journal of medicinal chemistry, Jan-16, Volume: 46, Issue:2
| Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens. |
AID206089 | In vitro anti-streptococcal activity against Streptococci species [38]* expressed as geometric mean | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID209767 | Minimum inhibitory concentration against Streptococcus pyogenes MTCC 442 | 2004 | Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
| Oxazolidinone: search for highly potent antibacterial. |
AID206727 | In vitro antibacterial activity against the methicillin-resistant Staphylococcus aureus 88 | 1999 | Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
| 3D QSAR studies on new oxazolidinone antibacterial agents by comparative molecular field analysis. |
AID68242 | In vitro antibacterial activity against Enterococcus faecium C6301 (E.f.2). | 1999 | Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
| Synthesis and in vitro activity of new oxazolidinone antibacterial agents having substituted isoxazoles. |
AID262228 | Antibacterial activity against Enterococcus faecalis ATCC 35550 | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials. |
AID133419 | Minimum inhibitory concentration of the subcutaneously administered compound evaluated against vancomycin resistant Enterococci faecium D3HM4 strain in mice | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID205897 | Minimum inhibitory concentration against Staphylococcus epidermidis MTCC 155 | 2004 | Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
| Oxazolidinone: search for highly potent antibacterial. |
AID68385 | In vitro antibacterial activity against Enterococcus faecium strain UC12712 | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID244814 | Minimum inhibitory concentration against Enterococcus faecalis A20688 | 2005 | Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
| Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid. |
AID206234 | Minimum inhibitory concentration against Staphylococcus epidermis UC12084 | 1998 | Journal of medicinal chemistry, Sep-10, Volume: 41, Issue:19
| Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring. |
AID308915 | Antibacterial activity against Enterococcus faecalis ATCC 14506 by broth microdilution method | 2007 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
| Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. |
AID28208 | Tmax value in Male Sprague-Dawley Rat at dose 10 (mg/kg iv) [tmax (h)]; ND denotes not reported | 2003 | Journal of medicinal chemistry, Jan-16, Volume: 46, Issue:2
| Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens. |
AID134121 | Protective dose of subcutaneously administered compound against intraperitoneally-induced septicaemia model (Staphylococcus aureus GR56 strain resistant to oxacillin) in murine | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID319151 | Toxicity in rat at 25 mg/kg for 30 days | 2008 | Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
| Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections. |
AID93890 | Minimum inhibitory concentration against Klebsiella pneumoniae ATCC 10031 | 2004 | Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
| Oxazolidinone: search for highly potent antibacterial. |
AID383561 | Antibacterial activity against Enterococcus faecalis ATCC 14506 by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID383563 | Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID226022 | Protective dose of subcutaneously administered compound against intraperitoneally-induced septicaemia model (Enterococci faecium D3HT7 strain ) in murine | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID209475 | In vitro antibacterial activity against Streptococcus pyogenes strain UC 152 | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID206839 | Minimum inhibitory concentration evaluated against Staphylococcus species resistant to ofloxacin [59]* | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID1369125 | Antibacterial activity against Acinetobacter baumannii ATCC 17978 transfected with pNT255 after 18 hrs by broth microdilution method | 2018 | Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
| A Synthetic Dual Drug Sideromycin Induces Gram-Negative Bacteria To Commit Suicide with a Gram-Positive Antibiotic. |
AID383567 | Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID226021 | Protective dose of subcutaneously administered compound against intraperitoneally-induced septicaemia model (Enterococci faecalis D2HT6 strain) in murine | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID308922 | Antibacterial activity against linezolid-resistant Staphylococcus aureus NRS 119 by broth microdilution method | 2007 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
| Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. |
AID83650 | Inhibitory activity against Haemophilus influenzae | 1996 | Journal of medicinal chemistry, Sep-27, Volume: 39, Issue:20
| New directions in antibacterial research. |
AID66405 | In vitro anti-enterococcal activity against enterococci species resistant to vancomycin [65]* expressed as geometric mean | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID319152 | Toxicity in dog at 25 mg/kg for 30 days | 2008 | Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
| Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections. |
AID112686 | In vivo antibacterial activity against Staphylococcus aures strain UC 9213 administered subcutaneously in mice | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID68244 | In vitro antibacterial activity against vancomycin-resistant Enterococcus faecium C6487 (VRE). | 1999 | Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
| Synthesis and in vitro activity of new oxazolidinone antibacterial agents having substituted isoxazoles. |
AID1471363 | Inhibition of coupled transcription-translation in Escherichia coli UC6782 30S ribosome subunit using ortho-nitrophenyl-beta-galactoside as substrate after 30 mins by spectrophotometry | 2018 | Journal of medicinal chemistry, 03-08, Volume: 61, Issue:5
| Causes and Significance of Increased Compound Potency in Cellular or Physiological Contexts. |
AID308914 | Antibacterial activity against Enterococcus faecalis ATCC 29212 by broth microdilution method | 2007 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
| Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. |
AID206833 | In vitro anti-staphylococcal activity against Staphylococcus species resistant to oxacillin [66]* expressed as geometric mean | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID308913 | Antibacterial activity against Staphylococcus epidermidis ATCC 12228 by broth microdilution method | 2007 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
| Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. |
AID133294 | Minimum inhibitory concentration of the subcutaneously administered compound evaluated against Staphylococcus agalactiae B1HT3 strain in mice | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID206228 | In vitro antibacterial activity against Staphylococcus epidermis strain UC 30031 | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID206236 | In vitro antibacterial activity against Staphylococcus aures strain ATCC 29213 | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID745403 | Antibacterial activity against Enterococcus faecium SR7940 clinical isolate assessed as growth inhibition by CLSI broth microdilution method | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID210379 | In vitro antibacterial activity against Streptococcus pneumoniae strain UC 9912 | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID745405 | Antibacterial activity against linezolid-resistant Staphylococcus aureus NRS271 assessed as growth inhibition by CLSI broth microdilution method | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID745374 | Inhibition of MAO-A in rat forebrain using [14C]5-HT as substrate at 30 uM incubated for 20 mins prior to substrate addition measured after 5 mins by liquid scintillation counting analysis relative to control | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID28087 | Cmax value in Male Sprague-Dawley Rat at dose 25 (mg/kg po) | 2003 | Journal of medicinal chemistry, Jan-16, Volume: 46, Issue:2
| Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens. |
AID383558 | Antibacterial activity against Staphylococcus epidermidis ATCC 155 by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID28199 | Plasma clearance in Male Sprague-Dawley Rat (25 mg/kg po); ND denotes not reported | 2003 | Journal of medicinal chemistry, Jan-16, Volume: 46, Issue:2
| Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens. |
AID262234 | Antibacterial activity against linezolid-resistant Staphylococcus aureus NRS 119 | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials. |
AID206237 | In vitro antibacterial activity against Staphylococcus aures strain UC 9213 | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID145139 | In vitro antibacterial activity against Mycobacterium tuberculosis strain H37Rv | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID745406 | Antibacterial activity against Staphylococcus aureus Smith assessed as growth inhibition by CLSI broth microdilution method | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID262226 | Antibacterial activity against Bacillus pumilus ATCC 14348 | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials. |
AID112685 | In vivo antibacterial activity against Staphylococcus aures strain UC 9213 administered perorally in mice | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID1369126 | Antibacterial activity against Acinetobacter baumannii ATCC 17978 transfected with pNT255:ADC-1 after 18 hrs by broth microdilution method | 2018 | Journal of medicinal chemistry, 05-10, Volume: 61, Issue:9
| A Synthetic Dual Drug Sideromycin Induces Gram-Negative Bacteria To Commit Suicide with a Gram-Positive Antibiotic. |
AID67400 | In vitro antibacterial activity against Enterococcus faecalis strain ATCC 29212 | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID67752 | Minimum inhibitory concentration against Enterococcus faecalis ATCC 14506 | 2004 | Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
| Oxazolidinone: search for highly potent antibacterial. |
AID133421 | Minimum inhibitory concentration of the subcutaneously administered compound evaluated against vancomycin resistant Enterococci faecium D3HT12 strain in mice | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID244819 | Minimum inhibitory concentration against Streptococcus pneumoniae A9585 | 2005 | Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
| Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid. |
AID308918 | Antibacterial activity against Staphylococcus aureus ATCC 33592 by broth microdilution method | 2007 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
| Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. |
AID208630 | Inhibitory activity against Streptococcus pneumoniae | 1996 | Journal of medicinal chemistry, Sep-27, Volume: 39, Issue:20
| New directions in antibacterial research. |
AID133306 | Minimum inhibitory concentration of the subcutaneously administered compound evaluated against vancomycin resistant Enterococci faecium D3HM3 strain in mice | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID206238 | In vitro antibacterial activity against Staphylococcus aures strain UC12673 | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID112681 | In vivo antibacterial activity against Enterococcus faecalis strain UC 12379 administered perorally in mice | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID262230 | Antibacterial activity against Staphylococcus aureus ATCC 9144 | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials. |
AID206470 | The compound was evaluated for its anti-bacterial activity against methicillin susceptible Staphylococcus aureus | 1998 | Journal of medicinal chemistry, Dec-17, Volume: 41, Issue:26
| Nitrogen-carbon-linked (azolylphenyl)oxazolidinones with potent antibacterial activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID206840 | Minimum inhibitory concentration evaluated against Staphylococcus species resistant to oxacillin [66]* | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID206451 | In vitro antibacterial activity against methicillin-susceptible Staphylococcus aureus (MSSA) C2214. | 1999 | Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
| Synthesis and in vitro activity of new oxazolidinone antibacterial agents having substituted isoxazoles. |
AID23886 | Plasma clearance in Male Sprague-Dawley Rat (10 mg/kg iv) | 2003 | Journal of medicinal chemistry, Jan-16, Volume: 46, Issue:2
| Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens. |
AID206055 | Inhibitory activity against methicillin-resistant Staphylococcus epidermidis (MRSE) | 1996 | Journal of medicinal chemistry, Sep-27, Volume: 39, Issue:20
| New directions in antibacterial research. |
AID262237 | Antibacterial activity against Streptococcus pyogenes ATCC 14289 | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials. |
AID206834 | In vitro anti-staphylococcal activity against Staphylococcus species resistant to oxacillin and ofloxacin[47]* expressed as geometric mean | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID16465 | Calculated partition coefficient (clogP) | 1999 | Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
| 3D QSAR studies on new oxazolidinone antibacterial agents by comparative molecular field analysis. |
AID66407 | In vitro anti-enterococcal activity against enterococci species susceptible to vancomycin [26]* expressed as geometric mean | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID83641 | The compound was evaluated for its anti-bacterial activity against Haemophilus influenzae UC 30063 | 1998 | Journal of medicinal chemistry, Dec-17, Volume: 41, Issue:26
| Nitrogen-carbon-linked (azolylphenyl)oxazolidinones with potent antibacterial activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID383562 | Antibacterial activity against multidrug-resistant Enterococcus faecalis ATCC 700802 by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID30967 | Harmonic mean apparent terminal disposition half-life [t1/2beta (h)] in Male Sprague-Dawley Rat at dose 10 (mg/kg iv) | 2003 | Journal of medicinal chemistry, Jan-16, Volume: 46, Issue:2
| Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens. |
AID226025 | Protective dose of subcutaneously administered compound against intraperitoneally-induced septicaemia model (vancomycin resistant Enterococci faecium D3HM3 strain ) in murine | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID1471364 | Binding affinity to Escherichia coli MRE600 50S ribosome after 10 mins by radioligand binding assay | 2018 | Journal of medicinal chemistry, 03-08, Volume: 61, Issue:5
| Causes and Significance of Increased Compound Potency in Cellular or Physiological Contexts. |
AID226023 | Protective dose of subcutaneously administered compound against intraperitoneally-induced septicaemia model (Staphylococcus pyogenes A1UC1 strain) in murine | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID383555 | Antibacterial activity against Bacillus pumilus ATCC 14884 by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID30153 | Volume distribution in Male Sprague-Dawley Rat (10 mg/kg iv) | 2003 | Journal of medicinal chemistry, Jan-16, Volume: 46, Issue:2
| Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens. |
AID28179 | Harmonic mean apparent terminal disposition half-life [t1/2beta (h)] in Male Sprague-Dawley Rat at dose 25 (mg/kg po); ND denotes not reported | 2003 | Journal of medicinal chemistry, Jan-16, Volume: 46, Issue:2
| Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens. |
AID41285 | Inhibitory activity against Bacteroides fragilis | 1996 | Journal of medicinal chemistry, Sep-27, Volume: 39, Issue:20
| New directions in antibacterial research. |
AID206450 | In vitro antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA) C6068. | 1999 | Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
| Synthesis and in vitro activity of new oxazolidinone antibacterial agents having substituted isoxazoles. |
AID383559 | Antibacterial activity against Enterococcus faecalis ATCC 35550 by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID41262 | In vitro antibacterial activity against Bacteroides fragilis strain ATCC 25285 | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID745373 | Inhibition of MAO-B in rat forebrain using [14C]PEA as substrate at 30 uM incubated for 20 mins prior to substrate addition measured after 10 mins by liquid scintillation counting analysis relative to control | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID262236 | Antibacterial activity against vancomycin-resistant Enterococcus faecalis ATCC 700802 | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials. |
AID202107 | Inhibitory activity against Streptococcus pneumoniae UC9912 | 2000 | Journal of medicinal chemistry, Mar-09, Volume: 43, Issue:5
| Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID133303 | Minimum inhibitory concentration of the subcutaneously administered compound evaluated against Staphylococcus pyogenes A1UC1 strain in mice | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID308912 | Antibacterial activity against Bacillus subtilis ATCC 6633 by broth microdilution method | 2007 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
| Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. |
AID66406 | In vitro anti-enterococcal activity against enterococci species resistant to vancomycin and teicoplanin [17]* expressed as geometric mean | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID71095 | In vitro antibacterial activity against Escherichia coli strain ATCC 25922 | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID262235 | Antibacterial activity against Enterococcus faecalis ATCC 14506 | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials. |
AID165190 | In vitro antibacterial activity against Pseudomonas aeruginosa strain ATCC 27853 | 1996 | Journal of medicinal chemistry, Feb-02, Volume: 39, Issue:3
| Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant gram-positive bacterial infections. |
AID29429 | Oral bioavailability in rat (Sprague-Dawley) (male) (dose 25 mg/kg p.o.) | 2003 | Journal of medicinal chemistry, Jan-16, Volume: 46, Issue:2
| Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens. |
AID206993 | The compound was evaluated for its anti-bacterial activity against methicillin resistant Staphylococcus epidermidis | 1998 | Journal of medicinal chemistry, Dec-17, Volume: 41, Issue:26
| Nitrogen-carbon-linked (azolylphenyl)oxazolidinones with potent antibacterial activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID745378 | Inhibition of human CYP2C9 assessed as tolbutamide hydroxylation after 20 mins by LC/MS/MS analysis | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID205559 | Minimum inhibitory concentration against Staphylococcus aureus ATCC 14154 | 2004 | Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
| Oxazolidinone: search for highly potent antibacterial. |
AID161942 | Minimum inhibitory concentration evaluated against pneumococci resistant to penicillin [29]* | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID206613 | In vitro antibacterial activity against the methicillin-resistant Staphylococcus aureus 88 | 1999 | Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
| 3D QSAR studies on new oxazolidinone antibacterial agents by comparative molecular field analysis. |
AID206830 | In vitro anti-staphylococcal activity against Staphylococcus species [91]* expressed as geometric mean | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID206223 | In vitro antibacterial activity against Staphylococcus epidermis (S.e.2) C2235. | 1999 | Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
| Synthesis and in vitro activity of new oxazolidinone antibacterial agents having substituted isoxazoles. |
AID745377 | Inhibition of human CYP1A2 assessed as ethoxyresorufin O-deethylation after 20 mins by fluorescence plate reader analysis | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID308926 | Antibacterial activity against Staphylococcus epidermidis ATCC 155 by broth microdilution method | 2007 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
| Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. |
AID1553368 | Antibacterial activity against Staphylococcus aureus JC9213 by CLSI based broth dilution assay | 2019 | Bioorganic & medicinal chemistry letters, 09-15, Volume: 29, Issue:18
| Incorporation of a chiral gem-disubstituted nitrogen heterocycle yields an oxazolidinone antibiotic with reduced mitochondrial toxicity. |
AID161929 | In vitro anti-streptococcal activity against pneumococci resistant to penicillin [29]* expressed as geometric mean | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID133304 | Minimum inhibitory concentration of the subcutaneously administered compound evaluated against vancomycin resistant Enterococci faecium D3AP9 strain in mice | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID308917 | Antibacterial activity against Staphylococcus aureus ATCC 29213 by broth microdilution method | 2007 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
| Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. |
AID209464 | In vitro antibacterial activity against Streptococcus pyogenes C6003 (S.p.2). | 1999 | Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
| Synthesis and in vitro activity of new oxazolidinone antibacterial agents having substituted isoxazoles. |
AID66560 | Minimum inhibitory concentration evaluated against enterococci species resistant to vancomycin and teicoplanin [17]* | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID103859 | Inhibitory activity against Moraxella catarrhalis UC30610 | 2000 | Journal of medicinal chemistry, Mar-09, Volume: 43, Issue:5
| Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID205561 | Minimum inhibitory concentration against Staphylococcus aureus ATCC 29213 | 2004 | Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
| Oxazolidinone: search for highly potent antibacterial. |
AID319150 | Oral bioavailability in dog at 25 mg/kg | 2008 | Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
| Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections. |
AID40326 | Minimum inhibitory concentration against Bacillus cereus MTCC 430 | 2004 | Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
| Oxazolidinone: search for highly potent antibacterial. |
AID308920 | Antibacterial activity against vancomycin-resistant Enterococcus faecium ATCC 700221 by broth microdilution method | 2007 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
| Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. |
AID206832 | In vitro anti-staphylococcal activity against Staphylococcus species resistant to ofloxacin [59]* expressed as geometric mean | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID132799 | compound was tested against Staphylococcus aureus UC9213 the vancomycin administered (sc) in mouse positive control expressed as ED50 values. | 1998 | Journal of medicinal chemistry, Sep-10, Volume: 41, Issue:19
| Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring. |
AID745407 | Antibacterial activity against Staphylococcus aureus SR20549 clinical isolate assessed as growth inhibition by CLSI broth microdilution method | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID206056 | Inhibitory activity against methicillin-sensitive Staphylococcus epidermidis (MSSE) | 1996 | Journal of medicinal chemistry, Sep-27, Volume: 39, Issue:20
| New directions in antibacterial research. |
AID262233 | Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials. |
AID67243 | In vitro antibacterial activity against Enterococcus faecalis C6291 (E.f.1). | 1999 | Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
| Synthesis and in vitro activity of new oxazolidinone antibacterial agents having substituted isoxazoles. |
AID226026 | Protective dose of subcutaneously administered compound against intraperitoneally-induced septicaemia model (vancomycin resistant Enterococci faecium D3HM4 strain ) in murine | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID54143 | Inhibitory activity against Corynebacterium | 1996 | Journal of medicinal chemistry, Sep-27, Volume: 39, Issue:20
| New directions in antibacterial research. |
AID208149 | Minimum inhibitory concentration Streptococcus pneumoniae UC9912 | 1998 | Journal of medicinal chemistry, Sep-10, Volume: 41, Issue:19
| Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring. |
AID308919 | Antibacterial activity against multidrug resistant Enterococcus faecalis ATCC 700802 by broth microdilution method | 2007 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
| Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. |
AID205560 | Minimum inhibitory concentration against Staphylococcus aureus ATCC 25923 | 2004 | Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
| Oxazolidinone: search for highly potent antibacterial. |
AID206469 | The compound was evaluated for its anti-bacterial activity against methicillin resistant Staphylococcus aureus | 1998 | Journal of medicinal chemistry, Dec-17, Volume: 41, Issue:26
| Nitrogen-carbon-linked (azolylphenyl)oxazolidinones with potent antibacterial activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID745404 | Antibacterial activity against Enterococcus faecalis SR1004 clinical isolate assessed as growth inhibition by CLSI broth microdilution method | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID308924 | Antibacterial activity against methicillin-resistant Streptococcus pyogenes ATCC 14289 by broth microdilution method | 2007 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
| Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. |
AID262229 | Antibacterial activity against Staphylococcus aureus ATCC 25923 | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials. |
AID383568 | Antibacterial activity against linezolid-resistant Staphylococcus aureus NRS 119 with G 2576T mutation by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID383570 | Antibacterial activity against multidrug-resistant Streptococcus pneumoniae ATCC 700904 by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID206222 | In vitro antibacterial activity against Staphylococcus epidermis (S.e.1) ATCC 1228. | 1999 | Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
| Synthesis and in vitro activity of new oxazolidinone antibacterial agents having substituted isoxazoles. |
AID133291 | Minimum inhibitory concentration of the subcutaneously administered compound evaluated against Enterococci faecium D3HT7 strain in mice | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID29723 | Tmax value in Male Sprague-Dawley Rat at dose 25 (mg/kg po) [tmax (h)] | 2003 | Journal of medicinal chemistry, Jan-16, Volume: 46, Issue:2
| Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens. |
AID319159 | Plasma concentration in human at 2000 mg, qid after 2 hrs | 2008 | Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
| Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections. |
AID745375 | Inhibition of human CYP3A4 assessed as terfenadine hydroxylation after 20 mins by LC/MS/MS analysis | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID262227 | Antibacterial activity against Staphylococcus epidermidis ATCC 155 | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials. |
AID207510 | Minimum inhibitory concentration against Staphylococcus aureus UC6685 | 1998 | Journal of medicinal chemistry, Sep-10, Volume: 41, Issue:19
| Piperazinyl oxazolidinone antibacterial agents containing a pyridine, diazene, or triazene heteroaromatic ring. |
AID209463 | In vitro antibacterial activity against Streptococcus pyogenes ATCC 8668 (S.p.1). | 1999 | Bioorganic & medicinal chemistry letters, Sep-20, Volume: 9, Issue:18
| Synthesis and in vitro activity of new oxazolidinone antibacterial agents having substituted isoxazoles. |
AID383557 | Antibacterial activity against Streptococcus pyogenes ATCC 14289 by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID308925 | Antibacterial activity against multidrug-resistant Streptococcus pneumoniae ATCC 700904 by broth microdilution method | 2007 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
| Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. |
AID308923 | Antibacterial activity against methicillin-resistant Staphylococcus aureus ATCC 700699 by broth microdilution method | 2007 | Bioorganic & medicinal chemistry letters, Sep-15, Volume: 17, Issue:18
| Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones. |
AID206838 | Minimum inhibitory concentration evaluated against Staphylococcus species [91]* | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID201410 | Inhibitory activity against Methicillin-susceptible Staphylococcus aureus UC9213 | 2000 | Journal of medicinal chemistry, Mar-09, Volume: 43, Issue:5
| Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl)oxazolidinones with expanded activity against the fastidious gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis. |
AID206091 | Minimum inhibitory concentration evaluated against Streptococci species [38]* | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID745376 | Inhibition of human CYP2D6 assessed as dextromethorphan O-demethylation after 20 mins by LC/MS/MS analysis | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID745381 | Antibacterial activity against methicillin-resistant Staphylococcus aureus SR3637 infected in JCL/ICR mouse systemic infection model assessed as mortality administered as po measured over 7 days | 2013 | European journal of medicinal chemistry, May, Volume: 63 | Antibacterial oxazolidinone analogues having a N-hydroxyacetyl-substituted seven-membered [1,2,5]triazepane or [1,2,5]oxadiazepane C-ring unit. |
AID28085 | Cmax value in Male Sprague-Dawley Rat at dose 10 (mg/kg iv) | 2003 | Journal of medicinal chemistry, Jan-16, Volume: 46, Issue:2
| Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens. |
AID67754 | Minimum inhibitory concentration against Enterococcus faecalis MTCC 439 | 2004 | Bioorganic & medicinal chemistry letters, Jun-21, Volume: 14, Issue:12
| Oxazolidinone: search for highly potent antibacterial. |
AID262238 | Antibacterial activity against penicillin-resistant Streptococcus pneumoniae ATCC 700904 | 2006 | Bioorganic & medicinal chemistry letters, Mar-15, Volume: 16, Issue:6
| Novel 4-N-substituted aryl pent-2-ene-1,4-dione derivatives of piperazinyloxazolidinones as antibacterials. |
AID133290 | Minimum inhibitory concentration of the subcutaneously administered compound evaluated against Enterococci faecalis D2HT6 strain in mice | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID319149 | Oral bioavailability in rat at 25 mg/kg | 2008 | Journal of medicinal chemistry, Apr-10, Volume: 51, Issue:7
| Linezolid (ZYVOX), the first member of a completely new class of antibacterial agents for treatment of serious gram-positive infections. |
AID383560 | Antibacterial activity against Staphylococcus aureus ATCC 25923 by broth microdilution technique | 2008 | European journal of medicinal chemistry, Apr, Volume: 43, Issue:4
| Synthesis and in vitro antibacterial activities of novel oxazolidinones. |
AID244813 | Minimum inhibitory concentration against Enterococcus faecium A24885 | 2005 | Bioorganic & medicinal chemistry letters, Jun-02, Volume: 15, Issue:11
| Synthesis and antibacterial activity of dihydro-1,2-oxazine and 2-pyrazoline oxazolidinones: novel analogs of linezolid. |
AID66559 | Minimum inhibitory concentration evaluated against enterococci species resistant to vancomycin [65]* | 2000 | Bioorganic & medicinal chemistry letters, Aug-07, Volume: 10, Issue:15
| Improved antibacterial activities of coumarin antibiotics bearing 5',5'-dialkylnoviose: biological activity of RU79115. |
AID1296008 | Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening | 2020 | SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
| Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening. |
AID1346986 | P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
AID1347160 | Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
AID1347159 | Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay | 2020 | Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
| Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors. |
AID1346987 | P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen | 2019 | Molecular pharmacology, 11, Volume: 96, Issue:5
| A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |